InvestorsHub Logo
Followers 233
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Wednesday, 10/16/2013 12:22:06 PM

Wednesday, October 16, 2013 12:22:06 PM

Post# of 429367
One thing I hope Amarin picks up on! Dr. Everett critiqued JELIS for the high LDL average and felt like statin should have been increased. This is very true, however without the statin increase EPA still lowered CV events. Goes both ways. Patients maximized on EPA to treat Trigs, could statins reduce cv outcomes further by decreasing LDL.

Another important point Amarin better get out, number of statin intolerant or statin intolerant to does increase!

God I hope Amarin reads this!!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News